missing translation for 'onlineSavingsMsg'
Learn More

QIAGEN QIAcard FTA DMPK

For collection, stabilization, processing, transport and archiving of biological samples. 4 sample areas per card.

Merk:  QIAGEN WB129242

 Bekijk meerdere types van dit product via de

Produktcode. 15346165

  • 800.00 / 100 stuks

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Beschrijving

Beschrijving

For collection, stabilization, processing, transport and archiving of biological samples. 4 sample areas per card.

QIAcard FTA DMPK Cards for Drug Metabolism Pharmacokinetic enable microvolume sampling with only 10 to 20 μL per sample and are designed for use with blood samples. The cards can also be used with colorless samples such as plasma, cerebrospinal fluid and urine.

QIAcard FTA DMPK-A and QIAcard FTA DMPK-B contains impregnated chemicals enabling protein denaturation to inactivate endogenous enzymes. Cell lysis releases endogenous cellular materials onto card. Stabilization of DNA allows resampling of blood spot for pharmacogenomics.Impregnated chemicals may interfere with mass spectrometry detection (e.g. ion suppression).

QIAcard FTA DMPK-C contain pure cellulose. No impregnated chemicals to interfere with analysis. Proteins are not denatured so cards may be better suited for protein based biomolecules and antibody studies.

Analysis:

Analysis primarily with HPLC or UHPLC followed by MS/MS detection, direct desorption MS techniques such as DESI. Methanol or aqueous/organic mixtures have been shown to work well for small molecules and aqueous buffers are recommended for proteins.

Select a good solvent for the analyte while maintaining compatibility with the HPLC conditions to be used. The choice of DMPK card depends on many factors such as the analyte chemical structure, extraction solvent and analysis workflow.

Specificatie

Specificatie

Card
For protein-based biomolecules, on-substrate cleanup has potential to convey greater analyte stability, requires fewer experimental animals
Contains impregnated chemicals enabling protein denaturation to inactivate endogenous enzymes. Cell lysis releases endogenous cellular materials onto card. Stabilization of DNA allows resampling of blood spot for pharmacogenomics.
Type B
100 cards
QIAcard FTA DMPK-B
Product Suggestions

Product Suggestions

Video's
Veiligheid en behandeling

Veiligheid en behandeling

Signaalwoord
  • Waarschuwing

Gevarencategorie
  • Acute toxiciteit Categorie 4
  • AQUATISCH GEVAAR OP LANGE TERMIJN Categorie 3 voor chronische toxiciteit

Gevarenaanduiding
  • H302 + H312 + H332-Schadelijk bij inslikken, bij contact met de huid en bij inademing.
  • H412-Schadelijk voor in het water levende organismen, met langdurige gevolgen.

Veiligheidsmaatregel
  • P280-Beschermende handschoenen/beschermende kleding/oog­bescherming/gelaatsbescherming dragen.
  • P273-Voorkom lozing in het milieu.
  • P304+P340-NA INADEMING: de persoon in de frisse lucht brengen en ervoor zorgen dat deze gemakkelijk kan ademen.
  • P312-Bij onwel voelen een ANTIGIFCENTRUM/arts/ raadplegen.
  • P501-Inhoud/verpakking afvoeren naar .

SDS
Documentatie

Documentatie

Certificates
Speciale aanbiedingen

Speciale aanbiedingen

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.